CN1160102C - Chinese medicine for curing female chronic inflammation - Google Patents

Abstract

The present invention relates to a traditional Chinese medicine for curing female chronic inflammation, which is characterized in that the present invention comprises sargentodoxa, patrinia, cortex moutan, gardenia, phellodendron bark, coix, spina gleditsiae, hiraute shiny bugleweed herb, beautiful sweetgum fruits, safflower, ground beeltle, angelica, chuanxiong rhizome, milkvetch root, dodder seed, akebia fruits and atractylodes rhizome. The present invention has the advantages of scientific compatibility, strict prescription, proper dose, proper specific function, good therapeutic effect, short treatment course, convenient taking, small dose, no side effect and low medicine price. The present invention overcomes the constraint of the compatibility principles of traditional Chinese patent medicines, learns from ancient experience, and does not stubbornly sticks to the ancient experience. The medicine has the characteristics of evil removal, no nourishment refusal, diarrhea resistance in spite of deficiency, combination of deficiency and excess, nourishment and diarrhea and mutual action and benefit.

Description

The Chinese medicine of treatment female chronic inflammation

Technical field

The present invention relates to a kind of Chinese medicine for the treatment of female chronic inflammation.

Background technology

In recent years, because artificial abortion, the extensive use of medicine stream, the growing and stretch of vile practices such as prostitution and whoring, and other system transmission of disease, diffusion etc., the sickness rate of female reproductive system infectious disease is obviously risen, through the adult women of clinical statistics about 70% in various degree the chronic genital disease of suffering from is arranged all, as: pelvic inflammatory disease, pelvic cavity hydrops, adnexitis, endometritis, the endometrium adhesion, ovarian cyst, cervical erosion, salpingitis, hydrosalpinx, obstruction of fallopian tube and infertility of causing by above-mentioned disease etc., health hazard to friend women is very big, and does not have ideal medicament thoroughly to effect a radical cure so far.

The chronic inflammatory disease of female reproductive system, doctor trained in Western medicine thinks because unclean sexual intercourse, artificial abortion, medicine stream and clinical examination, the transmission of infection institute of the not tight or adjacent internal organs of sterilization extremely in the treatment operating process, in the test chamber check, can find staphylococcus aureus, escherichia coli, gonorrhea diplococcus, chlamydia, mycoplasma etc., employed medicine mainly is a Novel Quinolone class antibacterial, take by the course of treatment, for acute gynecological inflammation or slighter pelvic inflammatory disease, curative effects such as adnexitis still can, but for chronic or more serious gynecological inflammation, then curative effect is very little or invalid, clothes can produce drug resistance for a long time, and are also fairly obvious to the infringement of hepatic and renal function.As: the ofloxacin tablet, to take medicine ten days, drug withdrawal seven days is a course of treatment, generally need take 2～4 courses of treatment, the course of treatment is long; The standard treatment of 2～4 courses of treatment of Novel Quinolone class antibacterial, clinical cure rate only 36%, 6 months relapse rates 62% wherein, weak curative effect; Take Novel Quinolone class antibacterial, 2～3 courses of treatment, untoward reaction such as headache in various degree, dizzy, erythra, cardiopalmus, insomnia promptly appearred in the patient, part patient also have stronger feel sick, gastrointestinal symptom such as vomiting; Taking Novel Quinolone class antibacterial, is that conscious curative effect descends since second course of treatment generally, and 3～4 courses of treatment, then curative effect was successively decreased, and reused, and produced drug resistance.And the use of Novel Quinolone class antibacterial generally is no more than 2 months the course of treatment, otherwise side effect is very big, and curative effect then falls far short.

The traditional Chinese medical science is thought, the chronic inflammatory disease of gynaecologic reproductive system belongs to damp-heat in lower-JIAO, hyperactivity of fire caused by deficiency of YIN, the strongly fragrant living heat of a specified duration of noxious dampness, heat in blood stagnation of QI institute extremely, clinical clearing away heat and cooling blood, eliminating damp, detoxifying, the soothing the liver methods that clear away heart-fire of adopting more, and square medicine stresses profit clearly more.Chinese patent medicine SANJIN PIAN commonly used, women scorching convalescence tablet, " Fubao " instant granular preparation, gynaecologic Fenqing pill, FUKE QIANJIN PIAN, FULE CHONGJI, FUYANJING JIAONANG, fuyanping capsules, HUAHONG PIAN etc.Through clinical statistics, above Chinese patent medicine uses 30～90 days cure rate average about 20%, total effective rate average out to about 61%, weak curative effect; General patient take Chinese patent medicine on average the phase of taking effect be 15～20 days, the basic healing then needs 3～6 months, even the longer time, the course of treatment is long; Because the course of treatment is long, medical expense is higher relatively, and quite a few patient can't bear, and the Halfway Stopping medication.

Technical scheme

The present invention is for solving the problem that prior art exists, summing up on the empirical basis of forefathers, through nearly thousand times drug screening, injectivity optimizing, adjustment, contrast and ten thousand routine patients' clinical verification, provide the Chinese medicine of the treatment female chronic inflammation of a kind of curative effect height, short treating period.

Prescription of the present invention is as follows:

The Chinese medicine of treatment female chronic inflammation, it is characterized in that: its active component is the extract of being made by the herbal raw material of following consumption proportion

Caulis Sargentodoxae 20～30 Herba Patriniae 20～30

Cortex Moutan 10～15 Fructus Gardeniae 10～15 Cortex Phellodendris 10～20

Semen Coicis 10～20 Spina Gleditsiae 15～25 Fructus Akebiaes 10～15

Rhizoma Atractylodis 10～15 Herba Lycopi 10～15 Rhizoma Chuanxiongs 10～15

Flos Carthami 10～15 Eupolyphaga Seu Steleophagas 10～20 Fructus Liquidambaris 15～25

Radix Astragali Preparata 15～25 Radix Angelicae Sinensis 15～25 Semen Cuscutae 10～25

Among the side of the present invention, Caulis Sargentodoxae, Herba Patriniae, Cortex Moutan, Fructus Gardeniae, Cortex Phellodendri have heat-clearing and toxic substances removing, removing heat from blood dampness, and through sick institute is monarch drug, are the keys that solves female chronic inflammation; Semen Coicis, Spina Gleditsiae, Herba Lycopi, Fructus Liquidambaris energy removing toxic substances and promoting pus discharge, inducing diuresis to remove edema, the cytothesis of help swelling reverses, and is ministerial drug; Flos Carthami, Eupolyphaga Seu Steleophaga, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Herba Lycopi can blood circulation promoting and blood stasis dispelling, the promoting the circulation of QI to induce diuresis that can nourish blood is again helped the monarch and his subjects mutually, can improve local circulation, promote focus to absorb, and improve curative effect, shorten the course of treatment.

The traditional Chinese medical science thinks that prolonged illness must be empty, the Radix Astragali, Radix Angelicae Sinensis, Semen Cuscutae, Fructus Akebiae energy strengthening vital QI to eliminate pathogenic factors, dispersing the stagnated live-QI to relieve the stagnation of QI, tonify without causing stagnation in the side, enhancing human body immunity power.

Chinese medicine of the present invention has the advantage of several respects:

One, Chinese medicine of the present invention course of treatment is one month, course cure rate at the cure rate of 82%, two course of treatment 92%, short treating period;

Two, Chinese medicine taking dose of the present invention and the similar Chinese patent medicine dosage of comparing is little, every day dosage only 20g (crude drug content) can reach expection;

Three, this Chinese medicine through animal model routinely Ji Liang ?10 times take, take continuously and do not see toxic and side effects in 12 months, take safe and reliable for a long time;

Four, the raw material of Chinese medicine kind that this Chinese medicine adopted is common Chinese herbal medicine, easily gathers, and the medicine source is extensive, easy-to-collection and infusion;

Five, the used Chinese herbal medicine of this Chinese medicine is cheap, and through measuring and calculating, every day, the medical herbs cost about 2 yuan, was 15%～20% of a similar Chinese patent medicine only.

The specific embodiment

Below in conjunction with embodiment the present invention is further described.

Embodiment 1

Prescription of the present invention one is as follows:

Caulis Sargentodoxae 20 Herba Patriniae 20

Cortex Moutan 10 Fructus Gardeniae 10 Cortex Phellodendris 10

Semen Coicis 10 Spina Gleditsiae 15 Fructus Akebiaes 10

Rhizoma Atractylodis 10 Herba Lycopi 10 Rhizoma Chuanxiongs 10

Flos Carthami 10 Eupolyphaga Seu Steleophagas 10 Fructus Liquidambaris 25

Radix Astragali Preparata 15 Radix Angelicae Sinensis 15 Semen Cuscutae 15

Embodiment 2

Prescription of the present invention two is as follows:

Caulis Sargentodoxae 25 Herba Patriniae 25

Cortex Moutan 10 Fructus Gardeniae 15 Cortex Phellodendris 15

Semen Coicis 15 Spina Gleditsiae 20 Fructus Akebiaes 15

Rhizoma Atractylodis 10 Herba Lycopi 12 Rhizoma Chuanxiongs 12

Flos Carthami 10 Eupolyphaga Seu Steleophagas 15 Fructus Liquidambaris 20

Radix Astragali Preparata 20 Radix Angelicae Sinensis 20 Semen Cuscutae 20

Embodiment 3

Prescription of the present invention three is as follows:

Caulis Sargentodoxae 30 Herba Patriniae 30

Cortex Moutan 15 Fructus Gardeniae 15 Cortex Phellodendris 20

Semen Coicis 20 Spina Gleditsiae 25 Fructus Akebiaes 10

Rhizoma Atractylodis 10 Herba Lycopi 10 Rhizoma Chuanxiongs 10

Flos Carthami 10 Eupolyphaga Seu Steleophagas 10 Fructus Liquidambaris 15

Radix Astragali Preparata 15 Radix Angelicae Sinensis 15 Semen Cuscutae 10

Embodiment 4

Prescription of the present invention four is as follows:

Caulis Sargentodoxae 20 Herba Patriniae 30

Cortex Moutan 12 Fructus Gardeniae 12 Cortex Phellodendris 12

Semen Coicis 12 Spina Gleditsiae 16 Fructus Akebiaes 12

Rhizoma Atractylodis 12 Herba Lycopi 12 Rhizoma Chuanxiongs 12

Flos Carthami 12 Eupolyphaga Seu Steleophagas 12 Fructus Liquidambaris 16

Radix Astragali Preparata 16 Radix Angelicae Sinensis 16 Semen Cuscutae 12

This form of Chinese drug can be electuary, also can be tablet, also can be oral liquid etc.

With the electuary is example, gets above-mentioned Chinese medicine, removes impurity, cleans and dries; Then effective component extracting adds firming agent in the effective ingredient that extracts, and solidified forming is an electuary, packs by the specification of every bag of 20g, puts in storage to be finished product.

Claims (1)

1. The Chinese medicine of 1 treatment female chronic inflammation, it is characterized in that: its active component is the extract of being made by the herbal raw material of following consumption proportion

   Caulis Sargentodoxae 20～30 Herba Patriniae 20～30

   Cortex Moutan 10～15 Fructus Gardeniae 10～15 Cortex Phellodendris 10～20

   Semen Coicis 10～20 Spina Gleditsiae 15～25 Fructus Akebiaes 10～15

   Rhizoma Atractylodis 10～15 Herba Lycopi 10～15 Rhizoma Chuanxiongs 10～15

   Flos Carthami 10～15 Eupolyphaga Seu Steleophagas 10～20 Fructus Liquidambaris 15～25

   Radix Astragali Preparata 15～25 Radix Angelicae Sinensis 15～25 Semen Cuscutae 10～25.